Viekira Pak Approved for Chronic HCV
New Drugs , News / October 4, 2016

The FDA approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease cal...

Skip to toolbar